.png)
Daiichi Sankyo Co is the Japanese pharmaceutical the company entering for June, 2019 the twenty of the world's largest in sales volumes.
History
2019: Return of GE Healthcare of exclusive rights on contrast agents
On June 27, 2019 it became known that companies Daiichi Sankyo Company, Limited (Daichi Sankyo Company, Limited) and GE Healthcare (Dzhi-I Helskea) agreed that Daiichi Sankyo will return to GE Healthcare company exclusive rights on further development and marketing in Japan of four approved diagnostic contrast agents and will assign the rights to the registration certificates (RC) in Japan of GE Healthcare Pharma Limited company ("Dzhi-I Helskea Pharm Limited"). Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |